- £5.53bn
- £6.35bn
- £1.68bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,242 | 1,193 | 1,345 | 1,611 | 1,683 |
Cost of Revenue | |||||
Gross Profit | 945 | 905 | 1,040 | 1,229 | 1,281 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 997 | 944 | 1,024 | 1,292 | 1,398 |
Operating Profit | 245 | 249 | 321 | 319 | 284 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 237 | 240 | 315 | 308 | 245 |
Provision for Income Taxes | |||||
Net Income After Taxes | 167 | 174 | 235 | 225 | 184 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 167 | 174 | 235 | 225 | 184 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 167 | 174 | 235 | 225 | 184 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.52 | 2.35 | 3.2 | 3.63 | 3.11 |
Dividends per Share |